PLoS ONE (Jan 2018)

Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.

  • María Buti,
  • María L Manzano,
  • Rosa M Morillas,
  • Montserrat García-Retortillo,
  • Leticia Martín,
  • Martín Prieto,
  • María L Gutiérrez,
  • Emilio Suárez,
  • Mariano Gómez Rubio,
  • Javier López,
  • Pilar Castillo,
  • Manuel Rodríguez,
  • José M Zozaya,
  • Miguel A Simón,
  • Luis E Morano,
  • José L Calleja,
  • María Yébenes,
  • Rafael Esteban

DOI
https://doi.org/10.1371/journal.pone.0199926
Journal volume & issue
Vol. 13, no. 6
p. e0199926

Abstract

Read online

[This corrects the article DOI: 10.1371/journal.pone.0184550.].